Precision NanoSystems is a global leader in nanoparticle technologies, solutions and services for developing
genomic medicines, including mRNA vaccines and therapeutics that define the future of medicine.
• NanoAssemblr® instruments with proprietary NxGen™ microfluidic mixers with scalable flow rates enable
increased nanoparticle stability, efficacy, yield and quality, accelerating timelines to develop robust and
reproducible formulations from discovery to commercial manufacturing.
• GenVoy-ILM™ off-the-shelf Research Use Only (RUO) lipid nanoparticle (LNP) delivery reagents accelerate
discovery and proof-of-concept studies to clinical development.
• End-to-end biopharmaceutical services span nanomedicine formulation from discovery to
commercialization, including proof-of-concept studies, optimization of formulation, lead candidate process
development, analytical development, scale-up and technology transfer for cGMP production.